Claudio U. Köser
Claudio U. Köser
Verified email at
Cited by
Cited by
Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak
CU Köser*, MTG Holden*, MJ Ellington*, ...
New England Journal of Medicine 366 (24), 2267-2275, 2012
Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance
WH Organization
World Health Organization, 2021
Routine use of microbial whole genome sequencing in diagnostic and public health microbiology
CU Köser, MJ Ellington, EJP Cartwright, SH Gillespie, NM Brown, ...
PLoS Pathogens 8 (8), e1002824, 2012
Technical report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)
World Health Organization
World Health Organization, 2021
The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee
MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ...
Clinical Microbiology and Infection 23 (1), 2-22, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis
P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ...
European Respiratory Journal 50 (6), 2017
Whole-genome sequencing to control antimicrobial resistance
CU Köser, MJ Ellington, SJ Peacock
Trends in Genetics 30 (9), 401-407, 2014
Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis
CU Köser, JM Bryant, J Becq, ME Török, MJ Ellington, MA Marti-Renom, ...
New England Journal of Medicine 369 (3), 290-292, 2013
Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology
S Reuter, MJ Ellington, EJP Cartwright, CU Köser, ME Török, T Gouliouris, ...
JAMA Internal Medicine 173 (15), 1397-1404, 2013
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints
S Niemann*, CU Köser* (*equal contributions), S Gagneux, C Plinke, ...
PLoS One 4 (10), e7407, 2009
Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives
T Schön, P Miotto, CU Köser, M Viveiros, E Böttger, E Cambau
Clinical Microbiology and Infection 23 (3), 154-160, 2017
Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis
World Health Organization
World Health Organization, 2018
A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak
S Reuter, TG Harrison, CU Köser, MJ Ellington, GP Smith, J Parkhill, ...
BMJ Open 3 (1), e002175, 2013
Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting
SYC Tong, MTG Holden, EK Nickerson, BS Cooper, CU Köser, A Cori, ...
Genome Research 25 (1), 111-118, 2015
Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex
S Feuerriegel, CU Köser, S Niemann
Journal of Antimicrobial Chemotherapy 69 (5), 1205-1210, 2014
What Is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis
J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ...
Antimicrobial Agents and Chemotherapy 62 (2), e01550-17, 2018
Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools.
V Schleusener, CU Köser, P Beckert, S Niemann, S Feuerriegel
Scientific Reports 7, 46327, 2017
Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak
ME Török, S Reuter, J Bryant, CU Köser, SV Stinchcombe, B Nazareth, ...
Journal of Clinical Microbiology 51 (2), 611-614, 2013
Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance
CU Köser, S Feuerriegel, DK Summers, JAC Archer, S Niemann
Antimicrobial Agents and Chemotherapy 56 (12), 6080-6087, 2012
Impact of fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824
S Feuerriegel*, CU Köser* (*equal contributions), D Baù, S Rüsch-Gerdes, ...
Antimicrobial Agents and Chemotherapy 55 (12), 5718-5722, 2011
The system can't perform the operation now. Try again later.
Articles 1–20